Purchase Order 75D30118P02540
Award Date 9/10/18
Potential Completion Date 9/9/19
Potential Value $150K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30341, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Immport Therapeutics, Inc., doing business as Antigen Discovery Inc. The $110,458.00 firm fixed price purchase order is for ADI Leptospirosis work, with a performance period ending August 18, 2020. Antigen Discovery is a biotechnology company that provides microarray products and services to support the CDC's disease detection and response efforts, including...
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Immport Therapeutics Inc., doing business as Antigen Discovery Inc., for $30,000.00. The contract is for the provision of microarray products and services to support detection and response efforts related to pathogens such as monkeypox virus, Brucella, SARS-CoV-2, and Leptospirosis. Immport Therapeutics is a biotechnology company specializing in high throughput...
- This is a $179,000.00 firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Immport Therapeutics Inc., doing business as Antigen Discovery Inc. The contract is for the provision of MPOX MICROARRAY products and services to support the CDC's detection and response efforts related to monkeypox virus. The contract has an ultimate completion date of August 31, 2024. Immport Therapeutics Inc. has previously supported the CDC, the U.S. Department of...
- This is a $5,680 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Immport Therapeutics Inc., doing business as Antigen Discovery Inc. The contract is for the analysis of protein samples, which supports NIAID's mission in infectious disease research and response. Immport Therapeutics is a biotechnology company that specializes in protein microarray technology and...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Immport Therapeutics Inc., doing business as Antigen Discovery Inc. The contract, valued at $15,000.00, is for the provision of falciparum custom protein microarrays. Immport Therapeutics is a biotechnology company that specializes in high-throughput protein microarray technology and related services, and has...
- This $221,889 firm fixed-price SBIR Phase I contract was awarded by the Department of Health and Human Services National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to HDT Bio Corp, a biopharmaceutical company, for "Diagnostics to Enable Malaria and Neglected Tropical Diseases". The contract originated from the NIH/Centers for Disease Control and Prevention (CDC) Small Business Innovation Research (SBIR) Program Solicitation PHS 2018-1, which sought...
- This is a SBIR Phase I contract award to Cytoimage Inc., a woman-owned small business, by the Centers for Disease Control and Prevention (CDC) of the Department of Health and Human Services (HHS). The award is for $149,531.00 and is a firm fixed price contract. The contract does not have a set-aside designation. The period of performance is from September 12, 2017 to March 11, 2018, with work to be performed in Atlanta, Georgia. The SBIR (Small Business Innovation Research) program is a...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $238,706 firm-fixed-price purchase order contract to Ai Biosciences, Inc., a minority-owned, self-certified small disadvantaged business, for an effective surface sampling and processing tool to detect microbial contamination. Ai Biosciences, a biotechnology research company, has previously received multiple SBIR awards from NASA, NIH, and CDC to develop advanced diagnostic technologies,...
- This $243,500 firm-fixed-price purchase order was awarded to Instadiagnostics Inc., a minority-owned, for-profit small business, by the Centers for Disease Control and Prevention (CDC) under the Small Business Innovation Research (SBIR) program. The contract is for the development of rapid diagnostic tests and devices related to SBIR Topic 37. Instadiagnostics Inc. has previously received federal grants from the CDC, Department of Defense, and National Institutes of Health for the development of...
- This federal contract award is for SBIR Phase II research and development work by Qoolabs Inc., a self-certified small disadvantaged business. The $749,999 cost-plus-fixed-fee contract was awarded on September 5, 2017 by the Department of Health and Human Services Centers for Disease Control and Prevention. The work is being performed in Atlanta, Georgia and involves the development of medical technologies related to infectious diseases, immunology, and cancer detection. This includes research...